^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    iNeo-Vac-R01

    i
    Associations
    News

    Trials

    Company:
    Hangzhou Neoantigen Therap
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms (NCT06019702)
    Phase 1
    Sir Run Run Shaw Hospital
    Recruiting
    Last update posted :
    09/11/2023
    Initiation :
    09/08/2023
    Primary completion :
    08/31/2027
    Completion :
    12/31/2027
    IL6 • IL2 • IL10
    |
    iNeo-Vac-R01
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms (NCT06026774)
    Phase 1
    Sir Run Run Shaw Hospital
    Recruiting
    Last update posted :
    09/11/2023
    Initiation :
    09/08/2023
    Primary completion :
    08/31/2027
    Completion :
    12/31/2027
    IL6 • IL2 • IL10
    |
    iNeo-Vac-R01
    Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms (NCT06026800)
    Phase 1
    Sir Run Run Shaw Hospital
    Recruiting
    Last update posted :
    09/11/2023
    Initiation :
    09/08/2023
    Primary completion :
    08/31/2027
    Completion :
    12/31/2027
    IL6 • IL2 • IL10
    |
    iNeo-Vac-R01